Substance
INOTUZUMAB OZOGAMICIN
Global reference: every product and company linked to this substance.
- cas: 635715-01-4
- ncit: C71542
- rxnorm: 1942950
- unii: P93RUU11P7
BESPONSA · CMC-544 · inotuzumab ozogamicin [INN] · INOTUZUMAB OZOGAMICIN [JAN] · INOTUZUMAB OZOGAMICIN [USAN] · Inotuzumab ozogamicin [WHO-DD] · PF-05208773 · WAY-207294
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| PFIZER INC. COMMON STOCK | BESPONSA | Q4 2023 | $65.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- BESPONSA · PFIZER INC. COMMON STOCK